treprostinil 0.053 MG Inhalation Powder [Yutrepia]

Verify with CMS →

treprostinil

RxCUI: 2714668

Important: Drug coverage and costs vary by plan and location. Verify coverage directly with your Medicare plan before filling a prescription. This is informational data only and should not replace advice from your healthcare provider or pharmacist.
14.9%
Plan Coverage
756
Plans Covering
T4.2
Avg Tier
97%
Prior Auth Required

What the CMS Formulary Data Shows for treprostinil 0.053 MG Inhalation Powder [Yutrepia]

Per the CMS 2026 Part D formulary file, treprostinil 0.053 MG Inhalation Powder [Yutrepia] (RxNorm concept RXCUI 2714668, generic name treprostinil) appears on 66 distinct formulary files spanning 756 Medicare Part D plan offerings - 14.9% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 1 to Tier 5, with a cross-plan average of Tier 4.2.

Real-world access to treprostinil 0.053 MG Inhalation Powder [Yutrepia] depends on utilization management as much as tier placement: 97% of covering formularies require prior authorization. 0% require step therapy. 80.3% apply quantity limits.

Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 3,017 Part D beneficiaries filled treprostinil 0.053 MG Inhalation Powder [Yutrepia] in 2023, with total plan-and-beneficiary spending of $436,921,533 and an average per-beneficiary annual cost of $144,819.87. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry treprostinil 0.053 MG Inhalation Powder [Yutrepia] today.

Coverage Details

Formularies covering
66
Plans covering
756
Coverage rate
14.9%
Tier range
Tier 1 – Tier 5
Average tier
Tier 4, Non-Preferred

Restrictions

Prior authorization required
97% of formularies
Step therapy required
0% of formularies
Quantity limits
80.3% of formularies

2023 Medicare Spending

Beneficiaries
3,017
Total spending
$436,921,533
Avg per beneficiary
$144,819.87

Tier Distribution Across Plans

25 plans
Tier 1, Preferred Generic
75 plans
Tier 5, Specialty

Medicare Advantage Plans (MA-PD) Covering treprostinil 0.053 MG Inhalation Powder [Yutrepia]

100 Medicare Advantage plans with Part D drug coverage include this drug.

Plan Insurer Tier PA Premium States
Florida Complete Care-Duals VIP (HMO-POS D-SNP) HPMP OF FLORIDA, INC. T1 Yes $0 FL
Mercy Care Advantage (HMO D-SNP) MERCY CARE T1 Yes $0 AZ
Mercy Care Advantage (HMO D-SNP) MERCY CARE T1 Yes $0 AZ
Mercy Care Advantage (HMO D-SNP) MERCY CARE T1 Yes $0 AZ
Elderplan Plus Long-Term Care (HMO-POS D-SNP) ELDERPLAN, INC. T1 Yes $0 NY
Health Choice Pathway (HMO D-SNP) HEALTH CHOICE ARIZONA, INC. T1 Yes $0 AZ
Healthfirst CompleteCare (HMO D-SNP) HEALTHFIRST HEALTH PLAN, INC. T1 Yes $0 NY
IMCare Classic (HMO D-SNP) ITASCA MEDICAL CARE T1 Yes $0 MN
Johns Hopkins Advantage MD D-SNP (HMO D-SNP) HOPKINS HEALTH ADVANTAGE, INC. T1 Yes $0 MD
MetroPlus UltraCare (HMO D-SNP) METROPLUS HEALTH PLAN, INC. T1 Yes $0 NY
Senior Whole Health SCO (HMO D-SNP) SENIOR WHOLE HEALTH, LLC T1 Yes $0 MA
Senior Whole Health SCO NHC (HMO D-SNP) SENIOR WHOLE HEALTH, LLC T1 Yes $0 MA
Molina One Care (HMO D-SNP) SENIOR WHOLE HEALTH, LLC T1 Yes $0 MA
SeniorCare Complete (HMO D-SNP) SOUTH COUNTRY HEALTH ALLIANCE T1 Yes $0 MN
AbilityCare (HMO D-SNP) SOUTH COUNTRY HEALTH ALLIANCE T1 Yes $0 MN
Alameda Alliance Wellness (HMO D-SNP) ALAMEDA ALLIANCE FOR HEALTH T1 Yes $0 CA
CCA One Care (HMO D-SNP) COMMONWEALTH CARE ALLIANCE, INC. T1 Yes $0 MA
CCA Senior Care Options (HMO D-SNP) COMMONWEALTH CARE ALLIANCE, INC. T1 Yes $0 MA
Florida Complete Care (HMO I-SNP) HPMP OF FLORIDA, INC. T1 Yes $4.80 FL
Florida Complete Care- In The Community (HMO-POS I-SNP) HPMP OF FLORIDA, INC. T1 Yes $4.80 FL
Elderplan For Medicaid Beneficiaries (HMO-POS D-SNP) ELDERPLAN, INC. T1 Yes $22.70 NY
VIVA Medicare Extra Value (HMO D-SNP) VIVA HEALTH, INC. T1 Yes $27.70 AL
VIVA Medicare Extra Care (HMO D-SNP) VIVA HEALTH, INC. T1 Yes $27.70 AL
Elderplan Advantage For Nursing Home Residents (HMO-POS I-SNP) ELDERPLAN, INC. T1 Yes $44.80 NY
MetroPlus Platinum Plan (HMO) METROPLUS HEALTH PLAN, INC. T1 Yes $58.80 NY
Sharp Direct Advantage Gold (HMO) SHARP HEALTH PLAN T5 Yes $0 CA
Sharp Direct Advantage VIP (HMO) SHARP HEALTH PLAN T5 Yes $0 CA
Sharp Direct Advantage VIP Plus (HMO) SHARP HEALTH PLAN T5 Yes $0 CA
Blue Medicare Advantage PPO (PPO) WELLMARK ADVANTAGE HEALTH PLAN, INC. T5 Yes $0 IA
BlueMedicare Premier (HMO) USABLE HMO, INC. T5 Yes $0 AR
BlueMedicare Classic Plus (HMO) USABLE HMO, INC. T5 Yes $0 AR
Medicare HMO Blue SaverRx (HMO-POS) BCBS OF MASSACHUSETTS HMO BLUE, INC. T5 Yes $0 MA
Clever Care Longevity (HMO) CLEVER CARE OF GOLDEN STATE, INC. T5 Yes $0 CA
Clever Care Value (HMO) CLEVER CARE OF GOLDEN STATE, INC. T5 Yes $0 CA
Clever Care Total+ (HMO C-SNP) CLEVER CARE OF GOLDEN STATE, INC. T5 Yes $0 CA
Clever Care Breathe+ (HMO C-SNP) CLEVER CARE OF GOLDEN STATE, INC. T5 Yes $0 CA
Clover Health Choice (PPO) CLOVER INSURANCE COMPANY T5 Yes $0 TX
Clover Health LiveHealthy (PPO) CLOVER INSURANCE COMPANY T5 Yes $0 GA
Clover Health LiveHealthy (PPO) CLOVER INSURANCE COMPANY T5 Yes $0 SC
Clover Health Choice (PPO) CLOVER INSURANCE COMPANY T5 Yes $0 PA
Clover Health LiveHealthy Giveback (PPO) CLOVER INSURANCE COMPANY T5 Yes $0 GA, SC
Clover Health Choice (PPO) CLOVER INSURANCE COMPANY T5 Yes $0 NJ
Clover Health Choice (PPO) CLOVER INSURANCE COMPANY T5 Yes $0 NJ
Clover Health Choice Giveback (PPO) CLOVER INSURANCE COMPANY T5 Yes $0 NJ
Clover Health Classic (HMO) CLOVER HMO OF NEW JERSEY INC. T5 Yes $0 NJ
Elderplan Flex (HMO-POS) ELDERPLAN, INC. T5 Yes $0 NY
Elderplan Select (HMO-POS I-SNP) ELDERPLAN, INC. T5 Yes $0 NY
Healthfirst Life Improvement Plan (HMO D-SNP) HEALTHFIRST HEALTH PLAN, INC. T5 Yes $0 NY
Healthfirst Connection Plan (HMO D-SNP) HEALTHFIRST HEALTH PLAN, INC. T5 Yes $0 NY
Healthfirst 65 Plus Plan (HMO) HEALTHFIRST HEALTH PLAN, INC. T5 Yes $0 NY

Frequently Asked Questions

Is treprostinil 0.053 MG Inhalation Powder [Yutrepia] covered by Medicare Part D?

Yes, treprostinil 0.053 MG Inhalation Powder [Yutrepia] is covered by 756 Medicare Part D plans (14.9% of all Part D formularies).

What tier is treprostinil 0.053 MG Inhalation Powder [Yutrepia] on Medicare Part D plans?

treprostinil 0.053 MG Inhalation Powder [Yutrepia] averages Tier 4.2 across Part D plans, ranging from Tier 1 to Tier 5.

Does treprostinil 0.053 MG Inhalation Powder [Yutrepia] require prior authorization?

97% of Part D formularies require prior authorization for treprostinil 0.053 MG Inhalation Powder [Yutrepia]. Step therapy: 0%. Quantity limits: 80.3%.

How much does Medicare spend on treprostinil 0.053 MG Inhalation Powder [Yutrepia]?

In 2023, total Medicare Part D spending on treprostinil 0.053 MG Inhalation Powder [Yutrepia] was $436,921,533, covering 3,017 beneficiaries. The average spend per beneficiary was $144,819.87.

Data sourced from the Centers for Medicare & Medicaid Services (CMS). See our methodology for details. Retrieved and formatted by PlainMedicare Editorial